Scientific Resources WTX-124 is an IL-2 Pro-Drug Conditionally Activated in Tumors and Able to Induce Complete Regressions in Mouse Tumor Models (Poster presented at AACR Annual Meeting 2021) 1.5 MB WTX-330, a Conditionally Activated IL-12 INDUKINETM Therapy, Releases IL-12 Selectively in the Tumor Microenvironment to Activate Anti-Tumor Immune Responses and Induce Regressions in Mouse Tumor Models (Poster presented at AACR Annual Meeting 2021) 2.9 MB First page « Previous page ‹ Page 1 Page 2 Current page 3
WTX-124 is an IL-2 Pro-Drug Conditionally Activated in Tumors and Able to Induce Complete Regressions in Mouse Tumor Models (Poster presented at AACR Annual Meeting 2021) 1.5 MB
WTX-330, a Conditionally Activated IL-12 INDUKINETM Therapy, Releases IL-12 Selectively in the Tumor Microenvironment to Activate Anti-Tumor Immune Responses and Induce Regressions in Mouse Tumor Models (Poster presented at AACR Annual Meeting 2021) 2.9 MB